139 related articles for article (PubMed ID: 7525501)
1. Prognostic value of beta human chorionic gonadotrophin in blood serum of patients with urinary bladder tumours.
Dobrowolski ZF; Byrska B; Dolezal M
Int Urol Nephrol; 1994; 26(3):301-6. PubMed ID: 7525501
[TBL] [Abstract][Full Text] [Related]
2. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.
Iles RK; Jenkins BJ; Oliver RT; Blandy JP; Chard T
Br J Urol; 1989 Sep; 64(3):241-4. PubMed ID: 2478247
[TBL] [Abstract][Full Text] [Related]
3. Ectopic human chorionic gonadotrophin (HCG) production: is the detection by serum analysis of HCG of clinical relevance in transitional cell carcinoma of the bladder?
Smith DJ; Evans HJ; Newman J; Chapple CR
Br J Urol; 1994 Apr; 73(4):409-12. PubMed ID: 8199829
[TBL] [Abstract][Full Text] [Related]
4. Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer.
Iles RK; Persad R; Trivedi M; Sharma KB; Dickinson A; Smith P; Chard T
Br J Urol; 1996 Jan; 77(1):61-9. PubMed ID: 8653319
[TBL] [Abstract][Full Text] [Related]
5. Serum and urinary levels of beta human chorionic gonadotrophin in patients with transitional cell carcinoma.
McLoughlin J; Pepera T; Bridger J; Williams G
Br J Cancer; 1991 May; 63(5):822-4. PubMed ID: 1710137
[TBL] [Abstract][Full Text] [Related]
6. Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy?
Moutzouris G; Yannopoulos D; Barbatis C; Zaharof A; Theodorou C
Br J Urol; 1993 Dec; 72(6):907-9. PubMed ID: 7508330
[TBL] [Abstract][Full Text] [Related]
7. The expression of beta human chorionic gonadotrophin (β-HCG) in human urothelial carcinoma.
Venyo AK; Herring D; Greenwood H; Maloney DJ
Pan Afr Med J; 2010; 7():20. PubMed ID: 21918707
[TBL] [Abstract][Full Text] [Related]
8. Trophoblastic metaplasia in urothelial carcinoma of the bladder.
Burry AF; Munn SR; Arnold EP; McRae CU
Br J Urol; 1986 Apr; 58(2):143-6. PubMed ID: 2421816
[TBL] [Abstract][Full Text] [Related]
9. [Biologic behavior of human chorionic gonadotropin hormone (HCGH) in transitional cell carcinomas of the bladder].
Moreno Sierra J; Gómez Ruiz JJ; Rodríguez Molina J; Blanco Jiménez E; Silmi Moyano A; Corral Rosillo J; Ortega Heredia D; Maestro de las Casas ML; Resel Estévez L
Arch Esp Urol; 1993; 46(6):469-72. PubMed ID: 7691043
[TBL] [Abstract][Full Text] [Related]
10. Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients.
Mora J; Gascón N; Tabernero JM; Rodríguez-Espinosa J; González-Sastre F
Br J Cancer; 1996 Oct; 74(7):1081-4. PubMed ID: 8855978
[TBL] [Abstract][Full Text] [Related]
11. Alpha-subunit and human chorionic gonadotropin-beta immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumours.
Grossmann M; Trautmann ME; Poertl S; Hoermann R; Berger P; Arnold R; Mann K
Eur J Clin Invest; 1994 Feb; 24(2):131-6. PubMed ID: 7515807
[TBL] [Abstract][Full Text] [Related]
12. Postoperative reduction of serum beta-HCG in testicular seminoma.
Sakashita S; Demura T; Gotoh T; Maru A; Koyanagi T
Int Urol Nephrol; 1988; 20(3):281-6. PubMed ID: 2456999
[TBL] [Abstract][Full Text] [Related]
13. An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta HCG).
Munro AJ; Nielsen OS; Duncan W; Sturgeon J; Gospodarowicz MK; Malkin A; Thomas GM; Jewett MA
Br J Cancer; 1991 Sep; 64(3):537-42. PubMed ID: 1716953
[TBL] [Abstract][Full Text] [Related]
14. Composition of intact hormone and free subunits in the human chorionic gonadotrophin-like material found in serum and urine of patients with carcinoma of the bladder.
Iles RK; Lee CL; Oliver RT; Chard T
Clin Endocrinol (Oxf); 1990 Sep; 33(3):355-64. PubMed ID: 1701369
[TBL] [Abstract][Full Text] [Related]
15. Free hCG-beta subunit as tumour marker in urothelial cancer.
Marcillac I; Cottu P; Théodore C; Terrier-Lacombe MJ; Bellet D; Droz JP
Lancet; 1993 May; 341(8856):1354-5. PubMed ID: 7684107
[No Abstract] [Full Text] [Related]
16. Inhibin as a marker for hydatidiform mole: a comparative study with the determinations of intact human chorionic gonadotrophin and its free beta-subunit.
Badonnel Y; Barbé F; Legagneur H; Poncelet E; Schweitzer M
Clin Endocrinol (Oxf); 1994 Aug; 41(2):155-62. PubMed ID: 7523000
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
Stevens MJ; Norman AR; Dearnaley DP; Horwich A
J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
[TBL] [Abstract][Full Text] [Related]
18. Spermatic cord beta-human chorionic gonadotropin levels in seminoma and their clinical implications.
Mumperow E; Hartmann M
J Urol; 1992 Apr; 147(4):1041-3. PubMed ID: 1372658
[TBL] [Abstract][Full Text] [Related]
19. Haemoglobin-F levels in urogenital cancers.
Müderrisoğlu C; Kansu E; Akdas A; Laleli Y; Firat D
Br J Urol; 1983 Jun; 55(3):264-7. PubMed ID: 6189544
[TBL] [Abstract][Full Text] [Related]
20. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance.
Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
Br J Cancer; 1995 Feb; 71(2):350-3. PubMed ID: 7530986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
